ANCHOR CAPITAL ADVISORS LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 262 filers reported holding HAEMONETICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ANCHOR CAPITAL ADVISORS LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2021$8,473,000
-81.5%
127,147
-69.2%
0.17%
-82.4%
Q1 2021$45,760,000
-13.7%
412,218
-7.7%
0.97%
-20.1%
Q4 2020$53,050,000
+31.0%
446,735
-3.8%
1.21%
+17.9%
Q3 2020$40,507,000
+39.4%
464,265
+43.2%
1.03%
-3.7%
Q2 2018$29,065,000
-43.4%
324,102
-53.8%
1.07%
-40.4%
Q1 2018$51,356,000
+18.8%
701,972
-5.7%
1.79%
+17.2%
Q4 2017$43,244,000
+26.5%
744,564
-2.3%
1.53%
+23.9%
Q3 2017$34,189,000
+11.7%
761,951
-1.7%
1.23%
+10.1%
Q2 2017$30,601,000
+37.9%
774,906
+41.7%
1.12%
+45.3%
Q1 2017$22,190,000
+46.4%
546,965
+45.0%
0.77%
+33.9%
Q4 2016$15,160,000
-28.1%
377,115
-35.2%
0.58%
-18.7%
Q3 2016$21,074,000
-19.7%
581,983
-35.7%
0.71%
+6.3%
Q2 2016$26,249,000
-17.7%
905,466
-0.6%
0.66%
-13.1%
Q1 2016$31,875,000
+10.3%
911,234
+1.7%
0.76%
+4.7%
Q4 2015$28,886,000
-3.4%
895,959
-3.1%
0.73%
-4.2%
Q3 2015$29,891,000
-22.7%
924,839
-1.1%
0.76%
-12.2%
Q2 2015$38,661,000
-9.5%
934,751
-1.8%
0.87%
-6.2%
Q1 2015$42,738,000
+12.2%
951,433
-6.6%
0.93%
+20.1%
Q4 2014$38,106,000
+3.8%
1,018,325
-3.1%
0.77%
+1.7%
Q3 2014$36,703,000
-6.8%
1,051,053
-5.8%
0.76%
-0.1%
Q2 2014$39,375,000
+8.0%
1,116,076
-0.3%
0.76%
+4.5%
Q1 2014$36,470,000
-22.2%
1,119,060
+0.6%
0.73%
-21.9%
Q4 2013$46,864,000
+2.3%
1,112,360
-3.1%
0.93%
-5.8%
Q3 2013$45,792,000
-8.5%
1,148,233
-5.1%
0.99%
-7.9%
Q2 2013$50,048,0001,210,3481.07%
Other shareholders
HAEMONETICS CORP shareholders Q1 2018
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders